Progesterone Regulates IL12 Expression in Pregnancy Lymphocytes by Inhibiting Phospholipase A2
- 31 January 2003
- journal article
- research article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 49 (1) , 1-5
Abstract
Par G, Geli J, Kozma N, Varga P, Szekeres‐Bartho J. Progesterone regulates IL12 expression in pregnancy lymphocytes by inhibiting phospholipase A2. AJRI 2003; 49:1–5 © Blackwell Munksgaard, 2003PROBLEM: Progesterone‐induced blocking factor (PIBF) is one of the pathways that mediate the immunological effects of progesterone. PIBF inhibits natural killer (NK) cytotoxic activity. Recently we showed that neutralization of PIBF results in an increased interleukin (IL)‐12 expression, which is corrected by cyclooxygenase inhibitors. As exogenous arachidonic acid (AA) voids the NK blocking effect of PIBF, it is likely that PIBF acts before the level of the cyclooxygenase enzyme. Therefore in this study we investigated the effect of PIBF neutralizing antibody and simultaneous phospholipase A2 inhibitor quinacrine (Q) treatment on IL‐12 production.METHODS: Pregnancy lymphocytes were treated with anti‐PIBF antibody or lipopolysaccharide (LPS) as a positive control, in the presence or absence of Q. IL‐12 expression by PBMC was detected by immunocytochemistry.RESULTS: Neutralization of PIBF as well as LPS treatment resulted in an increased IL‐12 expression, which was corrected by simultaneous Q treatment. Pre‐treatment of lymphocytes with progesterone prevented the stimulating effect of LPS on IL‐12 production.CONCLUSION: Progesterone binding of the lymphocytes is followed by the release of PIBF that inhibits AA release. The subsequent block of prostaglandin synthesis reduces IL‐12 production and results in a lowered cytotoxic NK activity, which may contribute to a normal pregnancy outcome.Keywords
This publication has 29 references indexed in Scilit:
- The Antiabortive Effect of Progesterone-Induced Blocking Factor in Mice Is Manifested by Modulating NK ActivityCellular Immunology, 1997
- The Expression of a Progesterone‐Induced Immunomodulatory Protein in Pregnancy LymphocytesAmerican Journal of Reproductive Immunology, 1995
- Preconceptional natural-killer-cell activity as a predictor of miscarriageThe Lancet, 1995
- Interleukin-12: A Proinflammatory Cytokine with Immunoregulatory Functions that Bridge Innate Resistance and Antigen-Specific Adaptive ImmunityAnnual Review of Immunology, 1995
- Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide.Journal of Clinical Investigation, 1995
- Expression of cyclooxygenase types 1 and 2 in human fetal membranes at termAmerican Journal of Obstetrics and Gynecology, 1995
- Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin‐2European Journal of Immunology, 1995
- Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?Immunology Today, 1993
- Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibodyCellular Immunology, 1990
- INFLUENCE OF ACETYLSALICYLIC ACID, AN INHIBITOR OF PROSTAGLANDIN SYNTHESIS, ON THE DURATION OF HUMAN GESTATION AND LABOURThe Lancet, 1973